Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
aducanumab
2
×
alzheimer's disease
biogen
2
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
gilead sciences
indiana blog main
indiana top stories
life sciences
2
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle genetics
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
accent therapeutics
affordable care act
aldeyra therapeutics
alex azar
amblyotech
asklepios biopharmaceutical
bayer
bioeurope
biomarin pharmaceutical
What
bio
biogen
2
×
roundup
activity
aducanumab
alzheimer’s
amyloid
angst
approvals
bagged
billions
biogen’s
brammer
clamped
covid
delays
developing
drug
economic
effects
failure
fast
fda
felt
including
ipo
isn’t
lost
lot
medicines
nash
new
news
oric’s
ripple
showing
spread
testing
week
work
Language
unset
Current search:
biogen
×
biogen
×
aducanumab
×
" life sciences "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More